A Randomized Phase II Study of Brentuximab Vedotin (NSC# 749710) and Crizotinib (NSC# 749005) in Patients with Newly Diagnosed Anaplastic Large Cell Lymphoma (ALCL)IND #117117
General Information
Age Group
Pediatrics/Children
Status
Active
Protocol Number
ANHL12P1
Offered At
Inova Children's Hospital
3300 Gallows Road
Falls Church, VA 22042
